Background illustration for clinical trials search

Paid Clinical Trials California

Discover 5,800 paid clinical trials in California. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Ancillary Nocturnal Urinary Symptoms Analyses for TRIUMPH

for
Nocturia
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: Female

Age: 60+

Code: NCT07829029

Recruiting
Active & Responsive

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

for
Pediatric Tumor of CNS, Pediatric Tumor of Brain,
Location: Orange CA
Sponsor: Neonc Technologies, Inc.

Sex: All

Age: 5 - 18

Code: NCT06357377

Phase 1, Recruiting
Active & Responsive

Voices Illuminating Solutions for Outdoor Workers' Needs and Safety

for
Air Pollution Exposure
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT07713264

Recruiting
Active & Responsive

Tensi+ for Treating Overactive Bladder

for
Overactive Bladder (OAB)
Location: New York NY, Toronto, Beverly Hills CA
Sponsor: Stimuli Technology

Sex: All

Age: 22+

Code: NCT07300904

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

for
PARKINSON DISEASE (Disorder)
Location: Farmington Hills MI, Decatur GA, Memphis TN,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07804615

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma

for
Metastatic Urothelial Carcinoma,
Location: Spokane WA, Los Angeles CA
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07815665

Phase 2, Phase 3, Recruiting
Active & Responsive

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

for
Obesity or Overweight, Weight-Related Comorbidity,
Location: Montreal, Joliette, Stouffville, Statesville NC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07776509

Phase 3, Recruiting
Active & Responsive

The Impact of Dietary Salt on the Severity of Eczema

for
Eczema, Atopic Dermatitis
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07447063

Recruiting
Active & Responsive

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

for
HSIL, High Grade Squamous Intraepithelial Lesion,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 21+

Code: NCT06949800

Phase 2, Recruiting
Active & Responsive

Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation

for
Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation,
Location: Boston MA, Chicago IL, Minneapolis MN, Los Angeles CA
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)

Sex: All

Age: 12 - 17

Code: NCT07286292

Phase 2, Recruiting
Active & Responsive

Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

for
Colorectal Cancer
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18+

Code: NCT07403981

Recruiting
Active & Responsive

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

for
Diabetic Retinopathy, Macular Edema
Location: Manchester CT, Bloomfield NJ, Cherry Hill NJ, Towson MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07705555

Phase 3, Recruiting
Active & Responsive

Varenicline for Smoking Reduction in Veterans Not Ready To Quit

for
Veterans, Tobacco Use Disorder, Cigarette Smoking,
Location: Durham NC, Minneapolis MN, San Diego CA
Sponsor: VA Office of Research and Development

Sex: All

Age: 21+

Code: NCT06966362

Recruiting
Active & Responsive

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

for
Esophageal Carcinoma, Gastric Cancer (Diagnosis),
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT07795749

Phase 2, Recruiting
Active & Responsive

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Boston MA, Philadelphia PA, Washington D.C. DC,
Sponsor: Girish Dhall, MD

Sex: All

Age: 16+

Code: NCT06502171

Phase 1, Recruiting
Active & Responsive

A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)

for
Chronic Hepatitis D Infection
Location: Garden Grove CA
Sponsor: Huahui Health

Sex: All

Age: 12 - 70

Code: NCT07499544

Phase 3, Recruiting
Active & Responsive

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

for
Advanced Unresectable Melanoma, Metastatic Melanoma
Location: San Francisco CA
Sponsor: Kevin Kim, MD

Sex: All

Age: 18+

Code: NCT07237100

Phase 2, Recruiting
Active & Responsive

Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

for
Achondroplasia
Location: Montreal, Baltimore MD, Ottawa, Madison WI, Oakland CA
Sponsor: QED Therapeutics, a BridgeBio company

Sex: All

Age: 0 - 2

Code: NCT07169279

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

for
Diabetic Macular Edema (DME)
Location: Waterford CT, Hauppauge NY, Hagerstown MD,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT07734844

Phase 3, Recruiting
Active & Responsive

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

for
Hodgkin Lymphoma, Adult, Refractory Hodgkin Lymphoma,
Location: San Francisco CA
Sponsor: Michael Spinner, MD

Sex: All

Age: 18+

Code: NCT07021989

Phase 2, Recruiting

Popular cities in California

With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.

Why choose California for clinical trials?

The state of California offers a variety of benefits for participants in clinical trials. Firstly, because the state is home to leading research institutions, it provides participants with access to cutting-edge treatments and advanced medical technologies before they become widely available. These institutions are equipped with state-of-the-art facilities and staffed by top experts, ensuring high-quality care and rigorous monitoring throughout the study.

California's diverse and innovative research landscape offers a wide range of study options, enhancing the likelihood of finding a trial that matches specific health needs. Moreover, the state's adherence to stringent regulatory and ethical standards ensures that trials are conducted with the utmost integrity and participant protection.

Common conditions studied in California

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in California